The Zhejiang Provincial Key Lab of Cardiovascular Disease Diagnosis and Treatment was established in December 2009. Currently, the lab has 26 research staffs, including 12 faculty members (professors of all ranks), 4 lecturers and 10 technical instructors.

The lab's research focuses are:
1. Stem cell therapy for heart failure;
2. Basic and clinical study of heart valve disease;
3. Early diagnosis and intensive intervention of coronary heart disease;
4. Basic and translational study of heart failure.

At present, the lab is well funded with many sources, such as the National Basic Research Program of China ("973" project), the National High-Tech R&D Program of China ("863" project), the Major National R&D Project, the National Science and Technology Support Program and the Program Research Grants from the National Natural Science Foundation. The total funding amount is over CNY 60 million.

Within the past five years, more than 60 peer-reviewed research papers have been published. Some papers are published in prestigious journals in the field of biomedical sciences and cardiovascular biology, such as Journal of Clinical Investigation, Circulation Research, Stem Cells, Journal of Interventional Cardiology, etc.

In the past few years, the lab has made contributions to the development of cardiovascular disease therapy. They have won several scientific awards, including the second prize of National Science and Technology Progress,  twice the first prize of Science and Technology Award of Zhejiang Province. Dr. Jian’an Wang, Director of the lab, won Bethune Medal in 2012, Zhejiang Province Science and Technology Significant Contribution Award in 2015 and Wu Jieping  Innovation Award in 2015.